Record title

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

Record identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7380514

https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7380514

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

About this item

Full title

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2020, Vol.21 (5), p.655-663

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7380514

Language

English

Formats

Publication information

Publisher

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7380514

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7380514

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item